Cure HSPB8 and Everlum Bio Announce Strategic Collaboration to Accelerate Research

We are excited to announce that Cure HSPB8 has entered into a close collaboration with Everlum Bio. This partnership aims to accelerate research towards developing effective treatments for HSPB8 Myopathy, bringing us closer to our vision of a life free from the burdens of this rare disease. 

About Everlum Bio 

At Everlum Bio, their mission is to transform the drug discovery process by providing exceptional management of drug development, research, and data. They are dedicated to revolutionizing the rare disease industry and improving patients' lives worldwide through their industry-leading Cure Plan project management program. Everlum's approach ensures that parents and families don't need to be scientists, business owners, researchers, and project managers—Everlum is here to manage those aspects and much more. 

The Collaboration 

This collaboration between Cure HSPB8 and Everlum Bio will focus on: 

Accelerating Research: Leveraging Everlum's expertise in drug development and project management to speed up the discovery of treatments for HSPB8 Myopathy. 

Enhancing Outcomes: Working together to revolutionize the rare disease industry and bring new hope to those living with HSPB8 Myopathy through innovative and effective treatment strategies. 

Shared Mission and Vision 

Both organizations share a commitment to improving the lives of those affected by rare diseases. Cure HSPB8's mission to accelerate the drug development process, build a strong community, and advocate for the HSPB8 Myopathy community aligns perfectly with Everlum Bio's dedication to transforming the drug discovery process and managing complex research projects

Looking Forward 

This strategic collaboration marks a significant step forward in our journey to find a cure for HSPB8 Myopathy. By combining Cure HSPB8's deep understanding of the disease with Everlum Bio's exceptional management capabilities, we are confident that we can accelerate the development of effective treatments and improve the lives of those affected by this rare condition.